Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Array Technologies Inc ARRY

Industrials
Array Technologies, Inc. is a provider of utility-scale solar tracker technology. The Company manufactures ground-mounting tracking systems used in utility and distributed generation solar energy projects worldwide. The Company’s segments include Array Legacy Operations and STI Legacy Operations. Its principal products are a portfolio of integrated solar tracking systems comprised of software... see more

Recent & Breaking News (NDAQ:ARRY)

Pfizer to Acquire Array BioPharma

Business Wire June 17, 2019

Array BioPharma to Present at the Goldman Sachs 40?? Annual Global Healthcare Conference

PR Newswire June 4, 2019

Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference

PR Newswire May 29, 2019

Array BioPharma Announces Presentation of Updated Overall Survival from the Phase 3 COLUMBUS Trial of BRAFTOVI + MEKTOVI in advanced BRAF-mutant Melanoma at 2019 ASCO Annual Meeting

PR Newswire May 29, 2019

Array BioPharma to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

PR Newswire May 9, 2019

Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019

PR Newswire May 7, 2019

Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2019 on May 7, 2019

PR Newswire April 30, 2019

BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) and ERBITUX® (cetuximab) or panitumumab Recommended by the National Comprehensive Cancer Network® (NCCN) Guidelines as a Treatment Option for Patients with Advanced BRAF-mutant Colorectal

PR Newswire March 18, 2019

The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering

Benzinga.com  March 14, 2019

Array BioPharma to Present at the 39th Annual Cowen Health Care Conference

PR Newswire March 5, 2019

Array BioPharma to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

PR Newswire February 21, 2019

The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs

Benzinga.com  February 8, 2019

The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering

Benzinga.com  February 6, 2019

50 Biggest Movers From Yesterday

Benzinga.com  February 6, 2019

Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019

PR Newswire February 5, 2019

The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results

Benzinga.com  February 5, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs

Benzinga.com  February 3, 2019

Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2019 on February 5, 2019

PR Newswire January 29, 2019

Array BioPharma Announces 15.3 Months Median Overall Survival from the Safety Lead-in of the Phase 3 BEACON CRC Trial of the Combination BRAFTOVI®, MEKTOVI® and ERBITUX® in BRAF-Mutant Metastatic Colorectal Cancer

PR Newswire January 14, 2019

Array BioPharma to Present at the 37th Annual J.P. Morgan Healthcare Conference

PR Newswire December 20, 2018